Home Nuomile Re-enters China's Future Unicorn TOP100 with Breakthroughs in Regenerative Medicine

Nuomile Re-enters China's Future Unicorn TOP100 with Breakthroughs in Regenerative Medicine

Apr 25, 2026 16:21 CST Updated 16:21
Neo Modulus

Developer of Human Tissue Repair and Organ Regeneration Products

Image


555.jpg


On April 24, 2026, at the scene of the 10th "All Things Grow" Conference, the China Investment Development Promotion Association, in collaboration with Micro Chain, officially released2026Future Chinese UnicornTOP100List》(hereinafter referred to as "the List"), proactively identifying a group of emerging companies in strategic emerging industries and future fields with disruptive innovation capabilities and high growth potential, outlining the landscape of China's future industrial development from a professional perspective.



The list closely follows the national future industry layout orientation, focusing on artificial intelligence and embodied intelligence, advanced manufacturing and future energy,Biomanufacturing, as well as future industries such as aerospace, quantum technology, and brain-computer interfaces, establish selection criteria, focus on future unicorn enterprises with rapid development and significant growth potential, ensure the innovation and growth of selected enterprises, and identify "potential stocks" capable of leading the development of future industries.

With hardcore scientific and technological innovation capabilities, strong growth momentum, and mature industrialization capabilities in the fields of regenerative medicine and tissue engineering,Neo Modulus Once Again Honored to Be Shortlisted,Continues to lead the high-end implantable medical device track.



Image


画板 1.png


Image
Image
Image
Image
Image
Image
Image
Image
Image
Image


Statement:

This article is for news purposes only, and its content is solely intended for information dissemination or industry exchange.The content herein should not be regarded as an advertisement or representing any express or implied advertising, nor should it be deemed to contain any purpose of sale or promise of sale.For accurate information, please consult professional medical institutions and seek expert advice.

If any individual or media, website wants to reprint this article, please contact the official account for authorization and indicate the source of the reprint.


Copywriting: Jerry Typesetting: Jerry